S&P 500   3,327.77 (+0.64%)
DOW   27,201.52 (+1.39%)
QQQ   271.05 (+0.25%)
AAPL   440.25 (+0.36%)
MSFT   212.94 (-0.16%)
FB   249.12 (-0.28%)
GOOGL   1,479.09 (+0.39%)
AMZN   3,205.03 (+2.11%)
NVDA   451.47 (+0.53%)
CGC   19.21 (-0.57%)
BABA   264.91 (+1.03%)
TSLA   1,485.02 (-0.13%)
MU   51.05 (-0.49%)
GE   6.40 (+4.23%)
AMD   85.31 (+0.32%)
T   29.85 (-0.53%)
F   6.96 (+1.46%)
ACB   10.71 (-0.19%)
GILD   69.00 (-2.65%)
NFLX   502.11 (-1.48%)
DIS   127.61 (+8.80%)
BAC   25.39 (+1.52%)
BA   174.28 (+5.58%)
S&P 500   3,327.77 (+0.64%)
DOW   27,201.52 (+1.39%)
QQQ   271.05 (+0.25%)
AAPL   440.25 (+0.36%)
MSFT   212.94 (-0.16%)
FB   249.12 (-0.28%)
GOOGL   1,479.09 (+0.39%)
AMZN   3,205.03 (+2.11%)
NVDA   451.47 (+0.53%)
CGC   19.21 (-0.57%)
BABA   264.91 (+1.03%)
TSLA   1,485.02 (-0.13%)
MU   51.05 (-0.49%)
GE   6.40 (+4.23%)
AMD   85.31 (+0.32%)
T   29.85 (-0.53%)
F   6.96 (+1.46%)
ACB   10.71 (-0.19%)
GILD   69.00 (-2.65%)
NFLX   502.11 (-1.48%)
DIS   127.61 (+8.80%)
BAC   25.39 (+1.52%)
BA   174.28 (+5.58%)
S&P 500   3,327.77 (+0.64%)
DOW   27,201.52 (+1.39%)
QQQ   271.05 (+0.25%)
AAPL   440.25 (+0.36%)
MSFT   212.94 (-0.16%)
FB   249.12 (-0.28%)
GOOGL   1,479.09 (+0.39%)
AMZN   3,205.03 (+2.11%)
NVDA   451.47 (+0.53%)
CGC   19.21 (-0.57%)
BABA   264.91 (+1.03%)
TSLA   1,485.02 (-0.13%)
MU   51.05 (-0.49%)
GE   6.40 (+4.23%)
AMD   85.31 (+0.32%)
T   29.85 (-0.53%)
F   6.96 (+1.46%)
ACB   10.71 (-0.19%)
GILD   69.00 (-2.65%)
NFLX   502.11 (-1.48%)
DIS   127.61 (+8.80%)
BAC   25.39 (+1.52%)
BA   174.28 (+5.58%)
S&P 500   3,327.77 (+0.64%)
DOW   27,201.52 (+1.39%)
QQQ   271.05 (+0.25%)
AAPL   440.25 (+0.36%)
MSFT   212.94 (-0.16%)
FB   249.12 (-0.28%)
GOOGL   1,479.09 (+0.39%)
AMZN   3,205.03 (+2.11%)
NVDA   451.47 (+0.53%)
CGC   19.21 (-0.57%)
BABA   264.91 (+1.03%)
TSLA   1,485.02 (-0.13%)
MU   51.05 (-0.49%)
GE   6.40 (+4.23%)
AMD   85.31 (+0.32%)
T   29.85 (-0.53%)
F   6.96 (+1.46%)
ACB   10.71 (-0.19%)
GILD   69.00 (-2.65%)
NFLX   502.11 (-1.48%)
DIS   127.61 (+8.80%)
BAC   25.39 (+1.52%)
BA   174.28 (+5.58%)
Log in

NASDAQ:ESTAEstablishment Labs Stock Price, Forecast & News

$17.70
+0.20 (+1.14 %)
(As of 08/5/2020 04:00 PM ET)
Add
Compare
Today's Range
$17.00
Now: $17.70
$17.71
50-Day Range
$15.17
MA: $17.15
$18.68
52-Week Range
$7.56
Now: $17.70
$29.78
Volume104,395 shs
Average Volume106,875 shs
Market Capitalization$412.92 million
P/E RatioN/A
Dividend YieldN/A
Beta1.39
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic plastic surgery and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Divina 3D simulation systems to plastic surgeons for use in pre-surgical patient consultations and planning; and distributes Puregraft line of products that is used to remove blood, lipids, and other components from adipose tissue. The company sells its products through exclusive distributors and direct sales force in 60 countries worldwide. Establishment Labs Holdings Inc. was founded in 2004 and is headquartered in Alajuela, Costa Rica.
Read More
Establishment Labs logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.3Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 4.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.07 out of 5 stars


Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:ESTA
CUSIPN/A
CIKN/A
Phone506 2434 2400

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$89.57 million
Book Value$1.92 per share

Profitability

Net Income$-38,150,000.00

Miscellaneous

Employees505
Market Cap$412.92 million
Next Earnings Date8/6/2020 (Confirmed)
OptionableNot Optionable
$17.70
+0.20 (+1.14 %)
(As of 08/5/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ESTA News and Ratings via Email

Sign-up to receive the latest news and ratings for ESTA and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Establishment Labs (NASDAQ:ESTA) Frequently Asked Questions

How has Establishment Labs' stock been impacted by COVID-19 (Coronavirus)?

Establishment Labs' stock was trading at $15.15 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, ESTA shares have increased by 16.8% and is now trading at $17.70.
View which stocks have been most impacted by Coronavirus
.

Do Wall Street analysts recommend investors buy shares of Establishment Labs?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Establishment Labs in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Establishment Labs
.

When is Establishment Labs' next earnings date?

Establishment Labs is scheduled to release its next quarterly earnings announcement on Thursday, August 6th 2020.
View our earnings forecast for Establishment Labs
.

How can I listen to Establishment Labs' earnings call?

Establishment Labs will be holding an earnings conference call on Thursday, August 6th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Establishment Labs' earnings last quarter?

Establishment Labs Holdings Inc (NASDAQ:ESTA) issued its quarterly earnings results on Thursday, May, 7th. The company reported ($0.79) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.30) by $0.49. The firm earned $24.48 million during the quarter, compared to the consensus estimate of $23.10 million. Establishment Labs had a negative net margin of 48.39% and a negative return on equity of 75.95%.
View Establishment Labs' earnings history
.

What price target have analysts set for ESTA?

3 equities research analysts have issued 1 year price targets for Establishment Labs' shares. Their forecasts range from $20.00 to $35.00. On average, they expect Establishment Labs' share price to reach $26.00 in the next twelve months. This suggests a possible upside of 46.9% from the stock's current price.
View analysts' price targets for Establishment Labs
.

Has Establishment Labs been receiving favorable news coverage?

Press coverage about ESTA stock has trended somewhat negative on Wednesday, according to InfoTrie Sentiment. The research group rates the sentiment of press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Establishment Labs earned a coverage optimism score of -1.0 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 5.0 out of 10, indicating that recent press coverage is somewhat likely to have an impact on the company's share price in the next several days.
View the latest news about Establishment Labs
.

Who are some of Establishment Labs' key competitors?

What other stocks do shareholders of Establishment Labs own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Establishment Labs investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), Sientra (SIEN), Allergan (AGN), BCE (BCE), Canadian Imperial Bank of Commerce (CM), Conduent (CNDT), Canadian Natural Resources (CNQ), Chevron (CVX) and Evolus (EOLS).

Who are Establishment Labs' key executives?

Establishment Labs' management team includes the following people:
  • Mr. Juan Jose Chacon Quiros, Founder, CEO & Exec. Director (Age 47)
  • Mr. Salvador Santos Dada, Chief Operating Officer (Age 37)
  • Mr. Eddie De Oliveira, VP of Sales, Brazil (Age 36)
  • Ms. Renee M. Gaeta, Chief Financial Officer (Age 38)
  • Mr. Roberto De Mezerville, Chief Technology Officer (Age 39)

When did Establishment Labs IPO?

(ESTA) raised $50 million in an IPO on Thursday, July 19th 2018. The company issued 3,100,000 shares at a price of $15.00-$17.00 per share. Jefferies and Cowen served as the underwriters for the IPO and BTIG was co-manager.

What is Establishment Labs' stock symbol?

Establishment Labs trades on the NASDAQ under the ticker symbol "ESTA."

Who are Establishment Labs' major shareholders?

Establishment Labs' stock is owned by many different retail and institutional investors. Top institutional shareholders include BigSur Wealth Management LLC (0.63%), CWM LLC (0.53%), Cambridge Investment Research Advisors Inc. (0.07%) and MV Capital Management Inc. (0.02%). Company insiders that own Establishment Labs stock include David L Bonvenuto, Jw Asset Management, Llc, Mezerville Roberto De and Nicholas Sheridan Lewin.
View institutional ownership trends for Establishment Labs
.

Which institutional investors are selling Establishment Labs stock?

ESTA stock was sold by a variety of institutional investors in the last quarter, including BigSur Wealth Management LLC, and MV Capital Management Inc..
View insider buying and selling activity for Establishment Labs
.

Which institutional investors are buying Establishment Labs stock?

ESTA stock was purchased by a variety of institutional investors in the last quarter, including CWM LLC, and Cambridge Investment Research Advisors Inc.. Company insiders that have bought Establishment Labs stock in the last two years include David L Bonvenuto, Jw Asset Management, Llc, Mezerville Roberto De, and Nicholas Sheridan Lewin.
View insider buying and selling activity for Establishment Labs
.

How do I buy shares of Establishment Labs?

Shares of ESTA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Establishment Labs' stock price today?

One share of ESTA stock can currently be purchased for approximately $17.70.

How big of a company is Establishment Labs?

Establishment Labs has a market capitalization of $412.92 million and generates $89.57 million in revenue each year. The company earns $-38,150,000.00 in net income (profit) each year or ($1.86) on an earnings per share basis. Establishment Labs employs 505 workers across the globe.

What is Establishment Labs' official website?

The official website for Establishment Labs is www.establishmentlabs.com.

How can I contact Establishment Labs?

Establishment Labs' mailing address is Building B15 and 25 Coyol Free Zone, Alajuela G2, . The company can be reached via phone at 506 2434 2400 or via email at [email protected]

This page was last updated on 8/5/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.